LOS ANGELES, CA -- (Marketwired) -- 09/30/13 -- MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), today announced that MMR has received a Notice of Allowance ("NOA") from the United States Patent and Trademark Office for Patent Application Serial No. 13/714,694, entitled "Method for Providing a User with a Web-based Service for Accessing and Collecting Health Records." The announcement comes one day before as many as 30 million Americans can begin registering for insurance under the Affordable Care Act and ultimately could be offered Personal Health Records ("PHRs"). The newest patent enables users to access and collect their medical records, communicate with healthcare providers, manage prescriptions, and perform other functions using a wireless device amongst other systems to privately and securely access and share their protected health information wherever and whenever they need to. The patent will include 27 claims, a portion of which are directed toward methods for providing patients with a service to access and collect health records in a private manner, and represents a significant addition to MMR's existing U.S. patent portfolio which also includes 19 other pending U.S. applications. Additionally, the MMR patent portfolio includes issued patents and pending applications in other countries of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel, and European nations.
The newest patent follows MMR's U.S. Patent No. 8,498,883, received two months ago on July 30th, entitled "Method for Providing a User with a Service for Accessing and Collecting Prescriptions." The '883 patent has 28 claims directed toward providing users with the ability to access and manage prescriptions online by including features for sending prescriptions to the pharmacy, accessing prescriptions from the pharmacy, sending reminders and scheduling prescription refills and identifying adverse drug interactions.
MMRGlobal CEO Robert H. Lorsch said, "Consistent with the aims of current health privacy laws, the systems and methods used by MMR in its PHR and contained in this patent can provide additional levels of privacy to protect providers from inadvertently sharing certain health records without appropriate consent. For example, various laws recognize the importance of minors being able to prevent parents from accessing their health records and spouses being able to protect sensitive records from each other. Additional password protection features contained in this application allow for the protection of health records contained within a family account."
Lisa L. Dahm, Esq., MMR Vice President, Healthcare Regulatory Affairs, said, "There are a number of state and federal privacy laws which require that a patient's protected health information be treated and shared differently. This patent can help protect physicians and providers by helping force compliance with those regulations. For example, in a number of states treatment of a minor that pertains to substance abuse, pregnancy and mental health cannot be disclosed to anyone, even the minor's parents, while the disclosure of HIV test results without separate and specific authorization could expose a provider to being charged with a Class A Misdemeanor. This and other laws and regulations place heightened burdens on providers who send medical records to PHRs and patient portals as mandated under Stage 2 Meaningful Use requirements. Features in MyMedicalRecords PHR products and services help protect physician practices from making these and other errors."
MMR is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals. The newly allowed patent application also includes a Web-based system which provides for managing communications with healthcare providers, the ability to manage prescriptions and an emergency access feature allowing the patient to specify emergency information. MMR believes that there is growing demand for Personal Health Record systems and other patient portal systems which provide features such as these.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId/Specifid vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com.
All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property enforcement actions, infringement claims or litigation, intellectual property licenses, and future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Public Communications Co.
Most Popular Stories
- Fed Committee Optimistic About Growth Prospects
- Sales Show Samsung Needs Next Big Thing
- IBM Investing $3 Billion in Chip Research
- Emmys: The List of Nominees
- Average 30-Year Mortgage Rate Rises to 4.15 Percent
- Don't Expect Bank Earnings to Shine in Q2
- Boehner Says No to Palin's Call for Impeachment
- U.S. Wholesalers Cut Stockpiles as Sales Weaken
- Kerry Calls for Calm in Gaza
- N.D. Pipeline Cleanup Could Take Weeks